Case Study

Bringing Relief Home for Annie

Image

The Challenge

Annie is a single mother of three working full time who was recently diagnosed with rheumatoid arthritis (RA). Her care team prescribed Inflectra, an infusion therapy administered every eight weeks.

Annie lived an hour and a half from the nearest infusion center. Between work, parenting responsibilities, and travel time, she missed 6 months of treatment. As a result, she experienced severe flare-ups that made it difficult to work and care for her children.

The Leap Solution

After Annie’s employer partnered with Leap, a Leap Care Guide quickly connected with Annie and her prescribing physician to address the barriers preventing treatment adherence.

Within days:
• Annie’s care was transitioned to in-home infusions
• Medication delivery and scheduling were coordinated
• A consistent eight-week infusion schedule was established

Patient Impact

By bringing care directly into her home, Leap eliminated Annie’s travel burden and helped her stay consistent with treatment. Over time, Annie regained function in her hands and was able to return to everyday activities at work and at home.

She was so grateful for the support that she sent her Care Guide a thank-you note along with a photo of her hands showing her progress.

“Leap Health is a lifesaver. I’m back to being the mom my kids need. I would recommend Leap to everyone.”
— Annie, Leap member

Employer Impact

Through cost-efficient in-home infusion care and improved treatment adherence, Leap helped Annie’s employer realize $158,000 in claims-validated annual savings.

This is Leap

Personalized care that works for members and employers.

Share this post

More insights

Image
Education

The Infusion Cost Crisis: Why Medical Benefit Drug Spend Keeps Escalating

For employers, however, infusion care has quietly become one of the fastest-growing and least unders...

Read article
Image
News

Leap Joins the Castlight Ecosystem to Simplify Infusion Care

Leap has joined the Castlight ecosystem to give TPAs and employers a more transparent, predictable, ...

Read article
Image
Insights

Rebates, what rebates? Understanding pharmacy rebates for J-Code drugs

Pharmacy rebates are manufacturer-paid discounts, typically negotiated behind

Read article
Image
Education

Demystifying Specialty Drug Pricing Acronyms, and Why They All Fail Employers

Behind the exorbitant costs of infusion therapies, you’ll find layers of complexity—and three acrony...

Read article
Image
Clinical

Safely Infusing Immunoglobulin in the Home Setting: Clinical Considerations and Best Practices

Immunoglobulin (Ig) therapies are essential in the treatment of primary immunodeficiency (PID), chro...

Read article
Image
News

Leap and Amwins Partner to Deliver Low-Cost, Convenient Infusion Therapy

Leap and Amwins Rx, today announced a strategic collaboration that will bring significant benefits t...

Read article
Image
Insights

How Leap Reduces the Total Cost of Multiple Sclerosis Care

For patients requiring long-term MS infusions like Ocrevus or Tysabri, traditional hospital-based tr...

Read article
Image
News

Leap and Blackhawk Claims Service Partner to Reduce Specialty Medication Costs and Improve Patient Access

We're so excited to announce our strategic partnership with Blackhawk Claims Service, a leading thir...

Read article
Image
Insights

The High Cost of RA Infusions – and How Leap Fixes It

For many patients, biologic infusions such as Remicade, Actemra, and Orencia are essential but they ...

Read article
Image
Insights

Why Home Infusion Is Safe, Effective – and Preferred by Patients

More patients and employers are choosing home infusion as a safe, effective alternative to hospital-...

Read article